Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Affymetrix Inc.
Case Western Reserve University and TGen Select Affymetrix SNP Array 6.0 for Diabetes Study
June 27th, 2008
Affymetrix Inc. (Nasdaq:AFFX) announced that Case Western Reserve University and the Translational Genomics Research Institute (TGen) will use the Affymetrix Genome-Wide Human SNP Array 6.0 to discover genetic pathways associated with diabetic nephropathy (DN). Case Western is the coordinating center for the 11 centers conducting independent studies as part of the Family Investigation of Nephropathy and Diabetes (FIND) Consortium, a project launched by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in 1999. Over a five-year period, 11 recruitment centers across the United States pooled their resources to recruit and enroll more than 10,000...
Source: Health Business Week (2008-06-27)
|
